11-22-2015, 06:05 AM
With most products, you’d expect a flood of new supply to quickly drive back down a price spike caused by a temporary shortage. Not so in the topsy-turvy world of hospital pharmaceuticals. Just look at prices for glycopyrrolate, an everyday drug used to dry up secretions prior to surgery. After one of only two makers of the drug temporarily closed its factory in 2012 to fix quality control problems, Hikma Pharmaceuticals Plc raised prices on its injectable version more than 800 percent over the next year. Both manufacturers are now making the drug again, yet Hikma’s prices have only fallen slightly and remain more than eight times higher than they were in early 2013.
The Law of Pharma Pricing: What Goes Up Often Stays Up - Bloomberg Business
For his "Executive Decision" segment, Cramer spoke with Marc Benioff, chairman and CEO of Salesforce.com (CRM - Get Report) , which delivered a 2-cents-a-share earnings beat on better-than-expected revenue that rose 24% year over year. Benioff praised Salesforce as the fastest-growing enterprise software company ever, and said that this quarter his company saw revenue growth across the board, even in Europe and Asia. Among the notable deals this quarter were technical services giant Aecom (ACM) and Sprouts Farmers Market (SFM) , which is using Salesforce's customer service cloud to communicate with its customers.
Jim Cramer's 'Mad Money' Recap: You Can't Keep a Good Stock Down - TheStreet
It’s an idea Willy Wonka’s evil twin might have dreamed up: Chocolate that’s healthy, calorie-free, and no fun at all. Behold, the chocolate pill. Candy-makers are pumping up production of nutritional supplements with flavanols, a cocoa extract said to improve blood circulation.
Chocolate in a Pill: All of the Benefits, None of the Fun - Bloomberg Business
The European Central Bank is ready to act quickly to boost anemic inflation in the euro zone, its president said on Friday, offering the strongest hint yet that the bank will unveil fresh stimulus measures at its Dec. 3 meeting.
ECB willing to act fast to boost inflation, says Draghi | Reuters
Twelve months ago, he had just finished his first season in car racing and had just driven a grand prix car for the first time. At 17, he was being put forward as a reason to bring in a minimum age limit for drivers entering F1. There were question marks about him, and the morality and wisdom of having such a young driver with such limited experience. A year on from that, those questions marks are long gone, and Dutchman Verstappen is regarded as the revelation of the season - and his performances have put more focus on youth coming through.
Max Verstappen and Carlos Sainz both excellent in 2015 - McNish - BBC Sport